The panel of promoter CGIs in this study included KIRREL2 and SLC13A5, which have previously been identified as the differentially-methylated CGIs in pancreatic cancer and cloned using methylated CpG island amplification-representational difference analysis from pancreatic cancer cell lines (18). Here, SLC13A5 is linked to pancreatic neoplasm.